170 related articles for article (PubMed ID: 36244826)
21. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer.
Lin LL; Mutch DG; Rader JS; Powell MA; Grigsby PW
Gynecol Oncol; 2007 Jul; 106(1):215-20. PubMed ID: 17482665
[TBL] [Abstract][Full Text] [Related]
22. Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.
Alektiar KM; McKee A; Venkatraman E; McKee B; Zelefsky MJ; Mychalczak BR; Hoskins WJ; Barakat RR
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):707-13. PubMed ID: 12062616
[TBL] [Abstract][Full Text] [Related]
23. Lymph-vascular Space Involvement and/or p53 Overexpression Correlated With the Clinical Outcome of Early-stage Endometrial Cancer Patients Treated With Adjuvant Vaginal Brachytherapy.
Laliscia C; Gadducci A; Coccia N; Mattioni R; Fuentes T; Caretto M; Pistolesi S; Puccini P; Perrone F; Morganti R; Paiar F
Anticancer Res; 2023 Jan; 43(1):149-156. PubMed ID: 36585177
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant radiotherapy in Stage II endometrial carcinoma: Is brachytherapy alone sufficient for local control?
Paydar I; DeWees T; Powell M; Mutch DG; Grigsby PW; Schwarz JK
Brachytherapy; 2015; 14(4):427-32. PubMed ID: 25911995
[TBL] [Abstract][Full Text] [Related]
25. Radiation therapy improves disease-specific survival in women with Stage II endometrioid endometrial cancer-Brachytherapy may be sufficient.
Nwachukwu CR; Von-Eyben R; Kidd EA
Brachytherapy; 2018; 17(2):383-391. PubMed ID: 29198879
[TBL] [Abstract][Full Text] [Related]
26. Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.
Guntupalli SR; Zighelboim I; Kizer NT; Zhang Q; Powell MA; Thaker PH; Goodfellow PJ; Mutch DG
Gynecol Oncol; 2012 Jan; 124(1):31-5. PubMed ID: 22030404
[TBL] [Abstract][Full Text] [Related]
27. Survival and disease relapse in surgical stage I endometrioid adenocarcinoma of the uterus after adjuvant vaginal vault brachytherapy.
Kumar VJ; Nin CY; Kuei LY; Tan KH; Yeo R; Lam PY
Int J Gynecol Cancer; 2010 May; 20(4):564-9. PubMed ID: 20686374
[TBL] [Abstract][Full Text] [Related]
28. [High dose rate vaginal brachytherapy in endometrial cancer after surgery].
Moreau-Claeys MV; Brunaud C; Hoffstetter S; Buchheit I; Peiffert D
Cancer Radiother; 2011 Jun; 15(3):169-75. PubMed ID: 21237693
[TBL] [Abstract][Full Text] [Related]
29. A comparison of disease recurrence between robotic versus laparotomy approach in patients with intermediate-risk endometrial cancer.
Song J; Le T; Hopkins L; Fung-Kee-Fung M; Lupe K; Gaudet M; E C; Samant R
Int J Gynecol Cancer; 2020 Feb; 30(2):160-166. PubMed ID: 31871112
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant radiation therapy is associated with improved overall survival in high-intermediate risk stage I endometrial cancer: A national cancer data base analysis.
Gupta V; McGunigal M; Prasad-Hayes M; Kalir T; Liu J
Gynecol Oncol; 2017 Jan; 144(1):119-124. PubMed ID: 27793358
[TBL] [Abstract][Full Text] [Related]
31. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.
Simpkins F; Papadia A; Kunos C; Michener C; Frasure H; AbuShahin F; Mariani A; Bakkum-Gamez JN; Landrum L; Moore K; Thomas SG; Windhorn A; Rose PG
Int J Gynecol Cancer; 2013 Jan; 23(1):98-104. PubMed ID: 23221731
[TBL] [Abstract][Full Text] [Related]
32. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation.
McCloskey SA; Tchabo NE; Malhotra HK; Odunsi K; Rodabaugh K; Singhal P; Lele S; Jaggernauth W
Gynecol Oncol; 2010 Mar; 116(3):404-7. PubMed ID: 19944453
[TBL] [Abstract][Full Text] [Related]
33. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant therapy for early stage, endometrial cancer with lymphovascular space invasion: Is there a role for chemotherapy?
Beavis AL; Yen TT; Stone RL; Wethington SL; Carr C; Son J; Chambers L; Michener CM; Ricci S; Burkett WC; Richardson DL; Staley AS; Ahn S; Gehrig PA; Torres D; Dowdy SC; Sullivan MW; Modesitt SC; Watson C; Veade A; Ehrisman J; Havrilesky L; Secord AA; Loreen A; Griffin K; Jackson A; Viswanathan AN; Jager LR; Fader AN
Gynecol Oncol; 2020 Mar; 156(3):568-574. PubMed ID: 31948730
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes.
Multinu F; Garzon S; Weaver AL; McGree ME; Sartori E; Landoni F; Zola P; Dinoi G; Aletti G; Block MS; Gadducci A; Mariani A
Int J Gynecol Cancer; 2021 Apr; 31(4):537-544. PubMed ID: 33608453
[TBL] [Abstract][Full Text] [Related]
36. Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma.
Xiang M; Kidd EA
J Gynecol Oncol; 2020 Jul; 31(4):e39. PubMed ID: 31912686
[TBL] [Abstract][Full Text] [Related]
37. Overview of adjuvant radiotherapy on survival, failure pattern and toxicity in stage I to II endometrial carcinoma: a long-term multi-institutional analysis in China.
Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
BMC Cancer; 2022 Mar; 22(1):266. PubMed ID: 35287626
[TBL] [Abstract][Full Text] [Related]
38. Factors Predictive of Receiving Adjuvant Radiotherapy in High-Intermediate-Risk Stage I Endometrial Cancer.
McGunigal M; Pollock A; Doucette JT; Liu J; Chadha M; Kalir T; Gupta V
Int J Gynecol Cancer; 2018 Jun; 28(5):882-889. PubMed ID: 29538253
[TBL] [Abstract][Full Text] [Related]
39. The impact of adjuvant vaginal brachytherapy in women with Stage II uterine endometrioid carcinoma: Results of a National Cancer Database analysis.
Lee JK; Ghanem AI; Modh A; Burmeister C; Mahmoud O; Maxwell GL; Elshaikh MA
Brachytherapy; 2018; 17(2):319-325. PubMed ID: 29174935
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic
Kurnit KC; Fellman BM; Mills GB; Bowser JL; Xie S; Broaddus RR
Int J Gynecol Cancer; 2022 Jul; 32(7):869-874. PubMed ID: 35483739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
